EVISA - Who we are
The establishment of EVISA is funded by the EU through the Fifth Framework Programme (G7RT- CT- 2002- 05112).
Supporters of EVISA includes:
Particles floating in (not necessarily on) a liquid medium, or the mix of particles and liquid itself.
The term "suspension" was found in the following pages:
European Medicines Agency recommends to pull linear Gadolinium-based MRI contrast agents from market | EVISA's News
EMA Issues Final Opinion Limiting Gadolinium Contrast Agents in Body Scans | EVISA's News
Material database: National Institute of Standards and Technology (NIST) - SRM 616/617 - Trace Elements in Glass
FDA identifies no harmful effects to date with brain retention of gadolinium-based contrast agents for MRIs | EVISA's News
Gadolinium-based contrast agents induce gadolinium deposits in cerebral vessel walls | EVISA's News
FDA panel calls for warning labels on gadolinium-based contrast agents for MRI | EVISA's News
Roxarsone and it metabolites in organic fertilizer lead to human exposure to arsenic | EVISA's News
European Medicines Agency recomments to pull linear Gadolinium-based MRI contrast agents from market | EVISA's News
See the complete list of deadlines!
IMSC 2018: 22nd International Mass Spectrometry Conference
13. Symposium „Massenspektrometrische Verfahren der Elementspurenanalyse“ zusammen mit dem 26. ICPMS-Anwendertreffen
ICIA 2018: 1. International Conference on Ion Analysis
... more Events
What's new on EVISA's web site ?
EU seeking to restrict chemicals in tattoo inks over cancer fears
FDA Invites Comment on New Exposure Limits for Cadmium
Shimadzu enhances its mass spectrometry platform with the launch of a new Q-TOF system
EU restricts mercury fillings for children
... more News
You have forgotten your password ?
© 2003 - 2010 by European Virtual Institute for Speciation Analysis ( EVISA )